HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort

The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of Human Immunodeficiency Virus (HIV) viremia in patients living with HIV (PLWH) who switch a to two-drug antiretroviral therapy (2DR) containing lamivudin...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagnino, Vincenzo, Teti, Elisabetta, Compagno, Mirko, Coppola, Luigi, Salpini, Romina, Svicher, Valentina, Basso, Monica, Battagin, Giuliana, Panese, Sandro, Rossi, Maria Cristina, Scaggiante, Renzo, Zago, Daniela, Iannetta, Marco, Parisi, Saverio Giuseppe, Andreoni, Massimo, Sarmati, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919011/
https://www.ncbi.nlm.nih.gov/pubmed/33671934
http://dx.doi.org/10.3390/microorganisms9020396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919011/
https://www.ncbi.nlm.nih.gov/pubmed/33671934
http://dx.doi.org/10.3390/microorganisms9020396

Ejemplares similares